Status:
UNKNOWN
SAS in Patients With Bronchial Carcinoma
Lead Sponsor:
RWTH Aachen University
Conditions:
Sleep Apnea Syndrome
Bronchial Carcinoma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
In this study it will be analyzed how often the sleep apnea syndrome can be observed in patients with newly diagnosed lung cancer with the help of ApneaLink device by ResMed.
Detailed Description
Determination of the SAS- frequence in patients with bronchial carcinoma. The patients will be screened at home for 1 night with the ApneaLink device by ResMed. The apneaLink device is a standard scre...
Eligibility Criteria
Inclusion
- Patients with reasonable suspicion of bronchial carcinoma or histologically proven bronchial carcinoma, which has not been medicated until the study entry and
- Patients with sleep apnea who had recently been diagnosed with bronchial carcinoma.
Exclusion
- Pregnancy
- other already known malignancies or tumors
- Patients with non-invasive artificial respiration due to a chronic respiratory insufficiencies
Key Trial Info
Start Date :
April 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2016
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT02270853
Start Date
April 1 2014
End Date
December 1 2016
Last Update
February 18 2016
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Medizinische Klinik I Uniklinik RWTH Aachen
Aachen, North Rhine-Westphalia, Germany, 52074
2
Krankenhaus Merheim
Cologne, North Rhine-Westphalia, Germany, 51109
3
Florence-Nightingale Hospital
Düsseldorf, Germany, 40489